862.0000 -6.65 (-0.77%)
NSE Aug 28, 2025 15:31 PM
Volume: 1.4M
 

logo
Laurus Labs Ltd.
25 Jan 2025
862.00
-0.77%
Motilal Oswal
Laurus Lab (LAURUS) significantly beat our earnings estimates in 3QFY25, led by a scale-up in the CDMO segment. Commercial supplies (including launch quantities) led to strong 89% YoY growth in CDMO sales for the quarter.
Number of FII/FPI investors increased from 259 to 293 in Jun 2025 qtr.
More from Laurus Labs Ltd.
Recommended